Pharmaceutical Isolator Market is Anticipated to Reach USD 32,944.3 Million by 2023
Pharmaceutical Isolator Market: Information by Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Application (Aseptic Isolators, Containment Isolators)
Pharmaceutical Isolator Market: Information by Type (Open Isolator and Closed Isolator), Pressure (Positive Pressure and Negative Pressure), Application (Aseptic Isolators, Containment Isolators, Sampling/Weighing/Distribution Isolators, Fluid Dispensing Isolators and others) End User (Hospitals, Pharmaceutical & Biotechnology Companies, Research & Academic Laboratories and others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Global Forecast till 2027
Pharmaceutical Isolator Market Highlights
The GlobalPharmaceutical Isolator Marketis expected to touch a valuation of USD 32,944.3 million by 2023, as per the latest report by Market Research Future (MRFR). The explosive growth of the pharmaceutical industry is the primary driver of the market. Pharmaceutical isolators are imperative in the drug manufacturing pipeline by segregating drugs from people. High use of these systems in filling lines is expected to bolster market demand from 2018 to 2023 (forecast period).
Decontamination of aseptic systems, mixing of toxic compounds, and multi-product manufacturing tasks of pharmaceutical companies are other factors which can spur the pharmaceutical isolator market growth. Strict government policies regarding safety of employees are likely to influence the buying decisions of major drug manufacturers in the coming years. Low operational costs of these systems on the manufacturing process is another factor which can lead to its integration in modern setups. Increasing demand for devices or systems which can guarantee the potency and efficacy of drugs can positively impact the market. But the adoption of restricted access barrier systems (RABS) can create headwinds in its growth trajectory.
Request Free Sample Copy at:
The pharmaceutical isolator market can be segmented by type, pressure, application, and end-user.
By type, the market is segmented into open and closed isolator systems. The open system segment can register 8.56% CAGR over the forecast period to reach a valuation of USD 20,566.3 million by 2023. Continuous development of novel compounds can facilitate the segment’s growth. On the flip side, the closed system segment can exhibit a modest 6.75% CAGR owing to increased protection from airborne impurities.
By pressure, the market is divided into positive and negative pressure isolators. The former accounted for 55.5% share in 2017 and touted to experience 8.42% CAGR over the assessment period. On the other hand, the latter can accrue returns at 7.14% CAGR during the same period. This can be credited to its role as a bulwark for humans during production of toxic compounds.
Major market applications include sampling/weighing/distribution, product containment, fluid dispensing, aseptic filling, and others. Out of these, aseptic filling accounted for nearly 28% share of the pharmaceutical isolator market, followed by fluid dispensing and sampling/weighing/distribution segments. The segment can touch USD 9,449.6 million by 2023 at a CAGR of 8.37% over the forecast period owing to the demand for systems with minimal cracks or crevices. The fluid dispensing segment can exhibit the highest CAGR of 9.94% owing to the high toxicity of novel compounds used in drug manufacturing.
End-users in the pharmaceutical isolator market include hospitals, pharmaceutical & biotechnology companies, research & academic laboratories, and others. Among these, the pharmaceuticals & biotechnology segment accounted for 45.8% market share in 2017. It is predicted to experience 8.13% CAGR over the forecast period due to various guidelines mandated by drug regulatory agencies to ensure the safety of workers.
The pharmaceutical isolator market covers the latest trends and opportunities across Americas, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas lead the global market with 36.4% share in 2017, followed by Europe (34%) and APAC (24.7%). It can continue its reign till 2023 owing to adoption of latest devices and systems and sharp rise noticed in numbers of biotechnology laboratories. The region can reach a valuation of USD 12,142.2 million by 2023 by growing at 8.08% CAGR over the assessment period.
The APAC pharmaceutical isolator market is predicted to enjoy 8.73% CAGR during the forecast period owing to the booming pharmaceutical sector in China and India. The high growth is substantiated by presence of contract manufacturing organizations in these countries and demand for generic drugs.
Prominent players operating in the pharmaceutical isolator market include COMECER S.P.A. (Italy), Schematic Engineering Industries (India), Fedegari Autoclavi S.p.A (Italy), MBRAUN (Germany), Robert Bosch GmbH (Germany), NuAire Inc. (U.S.), VanRx Pharmasystems Inc. (Canada), Getinge AB (Sweden), Gelman Singapore Pte Ltd. (Singapore), Skan AG (Switzerland), IsoTech Design (Canada), Azbil Telstar (Spain), Hosokawa Micron Ltd. (U.K.), and LAF Technologies Pty Ltd. (Australia).
Browse Detailed TOC with COVID-19 Impact Analysis at:
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312